Fibrates in the management of AD and CVD risk
EAS Academy. Vrablik M. 04/24/17; 175512 Topic: Therapy
Disclosure(s): Honoraria and research support from Abbott and Mylan companies.
Michal Vrablik
Michal Vrablik

Free Content is available to all users. Create a sign in with just your name and email.

Access EAS content "anytime, anywhere" with the EAS Academy App for iOS and Android

For any questions contact us at

Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies